1.53
price down icon1.29%   -0.02
after-market アフターアワーズ: 1.60 0.07 +4.58%
loading
前日終値:
$1.55
開ける:
$1.58
24時間の取引高:
66,698
Relative Volume:
0.05
時価総額:
$3.44M
収益:
-
当期純損益:
$-33.44M
株価収益率:
-2.0281
EPS:
-0.7544
ネットキャッシュフロー:
$-28.30M
1週間 パフォーマンス:
-12.57%
1か月 パフォーマンス:
-22.73%
6か月 パフォーマンス:
-61.75%
1年 パフォーマンス:
-86.98%
1日の値動き範囲:
Value
$1.53
$1.60
1週間の範囲:
Value
$1.53
$1.77
52週間の値動き範囲:
Value
$1.53
$19.41

Nucana Plc Adr Stock (NCNA) Company Profile

Name
名前
Nucana Plc Adr
Name
セクター
Healthcare (1182)
Name
電話
-
Name
住所
-
Name
職員
28
Name
Twitter
@NuCana_news
Name
次回の収益日
2024-11-14
Name
最新のSEC提出書
Name
NCNA's Discussions on Twitter

Nucana Plc Adr Stock (NCNA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-03-03 ダウングレード Cowen Outperform → Market Perform
2020-10-22 開始されました Truist Buy
2020-07-24 開始されました Oppenheimer Outperform
2019-08-19 開始されました H.C. Wainwright Buy
2018-10-19 開始されました Piper Jaffray Overweight
2017-10-23 開始されました Citigroup Buy
2017-10-23 開始されました Jefferies Buy
2017-10-23 開始されました William Blair Outperform
すべてを表示

Nucana Plc Adr (NCNA) 最新ニュース

pulisher
Sep 30, 2024

Trading Day Triumph: NuCana plc ADR (NCNA) Ends at 2.45, a -10.91 Surge/Plunge - The Dwinnex

Sep 30, 2024
pulisher
Sep 27, 2024

Get in on NuCana plc ADR’s (NCNA) buy-in window today! - SETE News

Sep 27, 2024
pulisher
Sep 26, 2024

NuCana plc ADR Inc. (NCNA) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Sep 26, 2024
pulisher
Sep 26, 2024

NCNA’s price-to-sales ratio: Is it a good investment opportunity? - US Post News

Sep 26, 2024
pulisher
Sep 26, 2024

NuCana secures new US patent for cancer treatment NUC-7738 - Investing.com India

Sep 26, 2024
pulisher
Sep 26, 2024

Market Watch: NuCana plc ADR (NCNA)’s Noteworthy Drop, Closing at 3.05 - The Dwinnex

Sep 26, 2024
pulisher
Sep 19, 2024

Daily Market Movement: NuCana plc ADR (NCNA) Sees a -7.03 Decrease, Closing at 3.44 - The Dwinnex

Sep 19, 2024
pulisher
Sep 18, 2024

William Blair downgrades NuCana plc ADR (NCNA) rating to a Mkt perform - Knox Daily

Sep 18, 2024
pulisher
Sep 18, 2024

There is no doubt that NuCana plc ADR (NCNA) ticks all the boxes. - SETE News

Sep 18, 2024
pulisher
Sep 17, 2024

Wolfspeed Inc [WOLF] Investment Appeal on the Rise - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

Labcorp Holdings Inc. (LH) may enjoy gains as insiders got busy in the recent days - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

NuCana Stock Soars 151% on Upbeat Efficacy Data From Melanoma Study - Yahoo Finance

Sep 17, 2024
pulisher
Sep 16, 2024

NCNA’s Financial Health: Exploring NuCana plc ADR’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle

Sep 16, 2024
pulisher
Sep 16, 2024

Analyzing NCNA’s price-to-book ratio for the last quarter - US Post News

Sep 16, 2024
pulisher
Sep 16, 2024

Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September - Benzinga

Sep 16, 2024
pulisher
Sep 12, 2024

Endava PLC Sponsored ADR (DAVA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance

Sep 12, 2024
pulisher
Sep 12, 2024

Opera Limited Sponsored ADR (OPRA) Crossed Above the 20-Day Moving Average: What That Means for Investors - Yahoo Finance

Sep 12, 2024
pulisher
Sep 11, 2024

Did Jim Cramer Say Buy Arm Holdings PLC – ADR (NASDAQ:ARM) Industrial Stock Before Rate Cuts? - Yahoo Finance

Sep 11, 2024
pulisher
Sep 03, 2024

NuCana price target lowered to $25 from $150 at Oppenheimer - TipRanks

Sep 03, 2024
pulisher
Sep 02, 2024

In the Green: NuCana plc ADR (NCNA) Closes at 3.66, Up/Down -52.65 from Previous Day - The Dwinnex

Sep 02, 2024
pulisher
Aug 30, 2024

NuCana stock downgraded by William Blair after halted cancer study - Investing.com India

Aug 30, 2024
pulisher
Aug 29, 2024

NuCana halts NuTide:323 study on colorectal cancer - Investing.com

Aug 29, 2024
pulisher
Aug 29, 2024

NuCana Ends Phase 2 Cancer Study, Focuses on Promising Treatments - TipRanks

Aug 29, 2024
pulisher
Aug 21, 2024

Check out these key findings about NuCana plc ADR (NCNA) - SETE News

Aug 21, 2024
pulisher
Aug 20, 2024

NCNA’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle

Aug 20, 2024
pulisher
Aug 15, 2024

NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire Inc.

Aug 15, 2024
pulisher
Aug 15, 2024

NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update - The Bakersfield Californian

Aug 15, 2024
pulisher
Jul 22, 2024

NuCana shares receive $150 stock PT at Oppenheimer on upbeat trial prospects - Investing.com

Jul 22, 2024
pulisher
Jul 16, 2024

Sea Limited Sponsored ADR (SE) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance

Jul 16, 2024
pulisher
Jul 12, 2024

XPeng Inc. Sponsored ADR (XPEV) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance

Jul 12, 2024
pulisher
Jul 05, 2024

Co-Diagnostics (CODX) to Post Q2 Earnings: What's in Store? - Yahoo Canada Shine On

Jul 05, 2024
pulisher
Jun 20, 2024

NuCana's Biliary Tract Cancer Candidate Gets Orphan Drug Tag - Yahoo Singapore News

Jun 20, 2024
pulisher
Jun 05, 2024

NuCana Stops Patient Enrollment in Pancreatic Cancer Study - Yahoo Sport Australia

Jun 05, 2024
pulisher
Jun 03, 2024

Citi Appointed as Successor Depositary Bank for Iberdrola, S.A.’s ADR Programme - Yahoo Finance

Jun 03, 2024
pulisher
Jun 02, 2024

NuCana to Participate in the 2022 Jefferies Healthcare Conference - The Globe and Mail

Jun 02, 2024
pulisher
Jun 02, 2024

NuCana to Present at the Jefferies Virtual London Healthcare Conference - The Globe and Mail

Jun 02, 2024
pulisher
May 30, 2024

Blueprint Medicines Files NDA to FDA for Pralsetinib in MTC - Yahoo Lifestyle UK

May 30, 2024
pulisher
May 16, 2024

Protagonist Therapeutics' PTG-300 Gets FDA's Orphan Drug Tag - Yahoo New Zealand News

May 16, 2024
pulisher
May 16, 2024

Analysts Estimate Endava PLC Sponsored ADR (DAVA) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

May 16, 2024
pulisher
May 11, 2024

NuCana (NCNA) Looks Good: Stock Adds 5.7% in Session - Yahoo New Zealand News

May 11, 2024
pulisher
May 09, 2024

Bears are Losing Control Over NuCana PLC Sponsored ADR (NCNA), Here's Why It's a 'Buy' Now - Yahoo Lifestyle UK

May 09, 2024
pulisher
May 08, 2024

Should You Buy NuCana (NCNA) Ahead of Earnings? - Yahoo News UK

May 08, 2024
pulisher
May 07, 2024

NuCana (NCNA) to Report Q4 Earnings: What's in the Cards? - Yahoo Movies Canada

May 07, 2024
pulisher
May 07, 2024

Should You Buy ARM Holdings (ARM) Ahead of Earnings? - Yahoo Finance

May 07, 2024
pulisher
Mar 27, 2024

NuCana plc Announces Reverse ADS Split - TipRanks

Mar 27, 2024
pulisher
Mar 19, 2024

Why Sea Limited Sponsored ADR (SE) Might be Well Poised for a Surge - Yahoo Finance

Mar 19, 2024
pulisher
Mar 18, 2024

Why Opera Limited Sponsored ADR (OPRA) Outpaced the Stock Market Today - Yahoo Finance

Mar 18, 2024
pulisher
Jan 03, 2024

NuCana: Potential Turnaround In 2024 But Risky - Seeking Alpha

Jan 03, 2024
pulisher
Oct 26, 2023

Davion Enters into Agreement with The Bank of New York Mellon for ADR Programme and $30 Million IPO Fundraise - Yahoo Finance

Oct 26, 2023
pulisher
Aug 22, 2023

MARKET DATA - The Wall Street Journal

Aug 22, 2023
pulisher
Sep 28, 2022

Down 34.6% in 4 Weeks, Here's Why You Should You Buy the Dip in NuCana PLC Sponsored ADR (NCNA) - Yahoo Finance

Sep 28, 2022

Nucana Plc Adr (NCNA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):